miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin

• Published in: Medical science monitor 2018-07, Vol.24, p.5292-5300
• Main Authors: Chen, Yaqing, Wang, Xiaoxue, Yang, Mengchen, Ruan, Wendong, Wei, Wei, Gu, Dongmei, Wang, Jing, Guo, Xinling, Guo, Lingxia, Yuan, Yuhua
• Format: Article
• Language: English
• Subjects: Adult; Animals; Arthritis, Experimental - genetics; Arthritis, Experimental - metabolism; Arthritis, Experimental - pathology; Arthritis, Rheumatoid - genetics; Arthritis, Rheumatoid - metabolism; Arthritis, Rheumatoid - pathology; Bone Resorption - genetics; Bone Resorption - pathology; Cattle; Collagen Type II - administration & dosage; Female; Humans; Lab/In Vitro Research; Male; Mice; Mice, Inbred DBA; MicroRNAs - administration & dosage; MicroRNAs - biosynthesis; MicroRNAs - blood; MicroRNAs - genetics; MicroRNAs - metabolism; Middle Aged; Osteoclasts - metabolism; Osteoclasts - pathology; Osteoprotegerin - biosynthesis; Osteoprotegerin - genetics; Osteoprotegerin - metabolism; RANK Ligand - biosynthesis; RANK Ligand - metabolism; RAW 264.7 Cells; Receptor Activator of Nuclear Factor-kappa B - biosynthesis; Receptor Activator of Nuclear Factor-kappa B - metabolism; Synovial Membrane - metabolism; Synovial Membrane - pathology; Transfection; Young Adult
• ISSN: 1643-3750; 1234-1010; 1643-3750
• DOI: 10.12659/msm.908219

BACKGROUND Osteoprotegerin (OPG) inhibits bone resorption and binds with strong affinity to receptor activator of NF κB ligand (RANKL), thereby preventing RANKL from binding to its receptor RANK. Osteoclasts have documented effects on bone erosion of rheumatoid arthritis (RA). The aim of this study was to examine the role of miR-145-5p in the regulation of RA osteoclast differentiation and bone erosion. MATERIAL AND METHODS Expression of microRNA-145-5p in human peripheral blood mononuclear cells (PBMC) and synovial tissue was assayed by real-time polymerase chain reaction (RT-PCR). OPG, RANK, and RANKL expression in RAW-264.7 cells was examined by RT-PCR and Western blot analysis. Osteoclast formation was detected by tartrate-resistant acid phosphatase (TRAP) staining. The effect of miR-145-5p on predicted target mRNAs was examined by luciferase reporter assays. Collagen-induced arthritis (CIA) was induced by injecting DBA/1 mice with bovine type II collagen (CII), and miR-145-5p agomir was administered by intravenous injection. Morphological changes in the CIA joint were assessed by micro-computed tomography (CT) and histopathology. RESULTS miR-145-5p levels significantly increased in RA PBMC and synovial tissue compared with normal PBMC and osteoarthritis (OA) tissue. After transfection of RAW-264.7 cells with miR-145-5p, RANK and RANKL expression increased significantly, while OPG expression decreased significantly. TRAP staining results showed osteoclast numbers increased. Micro-CT analysis of the arthritic joints showed that the miR-145-5p agomir caused bone erosion in mice, and histopathological analysis revealed that miR-145-5p agomir aggravates cartilage erosion. CONCLUSIONS Our findings indicate that administration of miR-145-5p aggravates joint erosion in CIA mice. This suggests that miR-145-5p is a potential target for the treatment of RA.